| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |